GENETIC TECHNOLOGIES LIMITED

Active Harpenden

Non-trading company

0 employees website.com
Life sciences and medical technology Non-trading company
G

GENETIC TECHNOLOGIES LIMITED

Non-trading company

Founded 3 Jul 1998 Active Harpenden, United Kingdom 0 employees website.com
Life sciences and medical technology Non-trading company

Previous Company Names

TEMPLECO 406 LIMITED 3 Jul 1998 — 18 Sept 1998
Accounts Submitted 26 Nov 2025 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 5 Jul 2025 Next due 17 Jul 2026 1 month remaining
Net assets £2 £0 2024 year on year
Total assets £2 £0 2024 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

Rothamsted Research West Common Harpenden Hertfordshire AL5 2JQ United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for GENETIC TECHNOLOGIES LIMITED (03592326), an active life sciences and medical technology company based in Harpenden, United Kingdom. Incorporated 3 Jul 1998. Non-trading company. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type dormant
Next accounts 31 Mar 2026
Due by 31 Dec 2026 7 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£2.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Rothamsted Research Holdings Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

GENETIC TECHNOLOGIES LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 May 2026OfficersTermination of Patrick Dawson Bailey as director on 9 Mar 2026
22 May 2026OfficersAppointment of Professor Martin Roger Broadley as director on 9 Mar 2026
26 Nov 2025AccountsAnnual accounts made up to 31 Mar 2025
7 Aug 2025OfficersTermination of Angela Karp as director on 1 Aug 2025
7 Aug 2025OfficersAppointment of Professor Patrick Dawson Bailey as director on 1 Aug 2025
22 May 2026 Officers

Termination of Patrick Dawson Bailey as director on 9 Mar 2026

22 May 2026 Officers

Appointment of Professor Martin Roger Broadley as director on 9 Mar 2026

26 Nov 2025 Accounts

Annual accounts made up to 31 Mar 2025

7 Aug 2025 Officers

Termination of Angela Karp as director on 1 Aug 2025

7 Aug 2025 Officers

Appointment of Professor Patrick Dawson Bailey as director on 1 Aug 2025

Recent Activity

Latest Activity

Termination of Patrick Dawson Bailey as director on 9 Mar 2026

1 weeks ago on 22 May 2026

Appointment of Professor Martin Roger Broadley as director on 9 Mar 2026

1 weeks ago on 22 May 2026

Annual accounts made up to 31 Mar 2025

6 months ago on 26 Nov 2025

Termination of Angela Karp as director on 1 Aug 2025

9 months ago on 7 Aug 2025

Appointment of Professor Patrick Dawson Bailey as director on 1 Aug 2025

9 months ago on 7 Aug 2025